These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19738604)

  • 1. Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.
    Huang JH; Zhang SN; Choi KJ; Choi IK; Kim JH; Lee MG; Lee M; Kim H; Yun CO
    Mol Ther; 2010 Feb; 18(2):264-74. PubMed ID: 19738604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.
    Zhang SN; Choi IK; Huang JH; Yoo JY; Choi KJ; Yun CO
    Mol Ther; 2011 Aug; 19(8):1558-68. PubMed ID: 21468000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.
    Weng X; Kuang Y; Liu X; Chen Z; Zhu H; Chen H; Jiang B; Shen H
    Braz J Med Biol Res; 2011 Mar; 44(3):186-92. PubMed ID: 21243315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
    Oh E; Choi IK; Hong J; Yun CO
    Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.
    Youlin K; Li Z; Xin G; Mingchao X; Xiuheng L; Xiaodong W
    Hum Vaccin Immunother; 2013 Apr; 9(4):766-72. PubMed ID: 23295983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
    Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
    Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change of immunoactivity of dendritic cells induced by mouse 4-1BBL recombinant adenovirus.
    Youlin K; Xiaodong W; Xiuheng L; Zhiyuan C; Hengcheng Z; Hui C; Botao J
    Yonsei Med J; 2010 Jul; 51(4):594-8. PubMed ID: 20499429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
    Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.
    Youlin K; Jian K; Siming L; Li Z; Weiyang H; Chaodong L; Xin G
    Immunotherapy; 2015; 7(1):13-20. PubMed ID: 25572476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
    Ahn HM; Hong J; Yun CO
    Oncotarget; 2016 Dec; 7(51):84965-84980. PubMed ID: 27821803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L.
    Lu SC; Hansen MJ; Hemsath JR; Parrett BJ; Zell BN; Barry MA
    Hum Gene Ther; 2022 Mar; 33(5-6):250-261. PubMed ID: 34731019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.
    Yang Z; Zhang Q; Xu K; Shan J; Shen J; Liu L; Xu Y; Xia F; Bie P; Zhang X; Cui Y; Bian XW; Qian C
    PLoS One; 2012; 7(9):e44802. PubMed ID: 23028626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.
    Wang R; Freywald A; Chen Y; Xu J; Tan X; Xiang J
    Cell Mol Immunol; 2015 Jul; 12(4):456-65. PubMed ID: 25195511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8
    Chen D; Huang L; Zhou H; Zhang Y
    Front Immunol; 2021; 12():615089. PubMed ID: 33717103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
    Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
    Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.
    Li G; Wu X; Zhang F; Li X; Sun B; Yu Y; Yin A; Deng L; Yin J; Wang X
    J Cancer Res Clin Oncol; 2011 Apr; 137(4):695-703. PubMed ID: 20563597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.